This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Timing the Market, Is it Possible? - May 04, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Griffon (GFF) Q2 Earnings Beat Estimates
by Zacks Equity Research
Griffon (GFF) delivered earnings and revenue surprises of 21.05% and -2.71%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Berry Global Highlights Measures to Fight Coronavirus Outbreak
by Zacks Equity Research
Berry Global (BERY) highlights some of its initiatives for expanding the production of material required for face masks.
Here's Why You Should Avoid Betting on RBC Bearings (ROLL)
by Zacks Equity Research
RBC Bearings (ROLL) has been suffering from difficult end-market conditions, rising cost of sales and several other issues.
Griffon (GFF) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Griffon (GFF) have what it takes? Let's find out.
Healthy Business to Aid Danaher in Q1 Despite Coronavirus Woes
by Zacks Equity Research
Danaher's (DHR) healthy businesses are likely to aid, driven by segmental performances in the first quarter of 2020. However, concerns related to the coronavirus outbreak persist.
3M Teams Up With Cummins to Increase Filter Output for PAPRs
by Zacks Equity Research
3M (MMM) partners with Cummins to increase the production of filters for its powered air-purifying respirators to fight against the coronavirus pandemic.
When Does Market Timing Actually Work? - April 14, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
General Electric Take Multiple Debt Restructuring Actions
by Zacks Equity Research
General Electric (GE) commences multiple actions to strengthen its financial positions. Proceeds from the BioPharma divestment and new debt offerings have been used for reducing leverage.
Danaher Gives Update on Q1 Results, Withdraws 2020 Guidance
by Zacks Equity Research
Danaher (DHR) provides an update on first-quarter 2020 results and withdraws its earlier announced guidance for 2020 on the impacts of the coronavirus outbreak.
General Electric Withdraws 2020 View on Coronavirus Concerns
by Zacks Equity Research
General Electric (GE) suspends 2020 projections on uncertainties related to the coronavirus outbreak. Also, earnings in the first quarter are expected to be weaker than previously expected.
Macquarie (MIC) Surges: Stock Moves 9.3% Higher
by Zacks Equity Research
Macquarie (MIC) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Macquarie (MIC) Withdraws Guidance on Coronavirus Concerns
by Zacks Equity Research
Macquarie (MIC) withdraws guidance for 2020 and suspends the quarterly cash dividend on the impacts of the coronavirus outbreak.
Danaher (DHR) Prices Senior Notes Offering Worth Euro 750M
by Zacks Equity Research
Danaher (DHR) prices euro 750 million worth of senior notes offerings. The net proceeds will be used for satisfying generate corporate purposes, including repaying debts.
Xylem (XYL) Withdraws Guidance Based on Coronavirus Concerns
by Zacks Equity Research
Xylem (XYL) withdraws guidance for the first quarter and 2020, owing to the coronavirus outbreak.
Berry Global (BERY) Invests in Specialty Meltblown Asset
by Zacks Equity Research
Berry Global (BERY) increases its investment in an additional specialty meltblown asset for the production of high-efficiency filtration media for the EMEIA markets.
Danaher Closes Buyout of General Electric's BioPharma Business
by Zacks Equity Research
Danaher (DHR) completes the acquisition of General Electric's BioPharma business. The buyout will likely strengthen the company's biologics workflow solutions business.
Honeywell Increases N95 Face Mask Production at Phoenix Site
by Zacks Equity Research
Honeywell (HON) increases N95 face mask production at its Phoenix site to help contain the coronavirus pandemic.
United Technologies & Raytheon Get Final Approval for Merger
by Zacks Equity Research
United Technologies (UTX) and Raytheon receive all the regulatory approvals required for closing the merger of equals on Apr 3, 2020.
Why Griffon (GFF) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Griffon (GFF) have what it takes? Let's find out.
Danaher (DHR) Prices Euro 1.75B Worth Senior Notes Offering
by Zacks Equity Research
Danaher (DHR) prices euro 1.75 billion worth of senior notes offerings. The net proceeds will be used for satisfying generate corporate purposes, including repaying debts.
General Electric Announces Coronavirus' Impacts on Its Business
by Zacks Equity Research
General Electric's (GE) aviation segment seeks to lower the U.S. workforce by 10% on coronavirus concerns. The company announces various other measures to deal with the impact of the outbreak.
Honeywell Increases Face Mask Production to Fight Coronavirus
by Zacks Equity Research
Honeywell (HON) increases production of healthcare materials in its bid to contribute toward the fight against the coronavirus pandemic.
Top Ranked Value Stocks to Buy for March 24th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, March 24th
Danaher to Soon Close BioPharma Buyout, Receives FTC Approval
by Zacks Equity Research
Danaher (DHR) receives a go-ahead for the acquisition of GE's BioPharma business. The buyout will likely strengthen its biologics workflow solutions business.